Navigation Links
S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board

JERSEY CITY, N.J., Oct. 24, 2011 /PRNewswire/ -- S1 Pharmaceuticals, Inc. (S1) today announced that it has appointed Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to its Scientific Advisory Board.  Dr. Segraves and Dr. Pyke will help guide the clinical development of S1's lead product, Lorexys, as it prepares for Phase I clinical trials.

"We are pleased to be able to attract such knowledgeable and prominent individuals as Segraves and Pyke to participate as members of our Scientific Advisory Board," stated Nicolas G. Sitchon, MA, MBA, Chief Executive Officer of S1 Pharmaceuticals.  "The formation of a distinguished advisory board to provide medical, clinical, and strategic guidance to the Company marks the next step in the evolution of our Lorexys clinical development program."

Dr. Segraves is a professor of psychiatry at Case Western Reserve School of Medicine.  Among his scientific interests are the treatment of sexual disorders, the co-morbidity of sexual dysfunction with anxiety and depressive disorders, sexual side effects of pharmacological agents, and pharmacotherapy of sexual disorders.  Dr. Segraves has authored over 200 publications in the area of human sexuality, numerous international presentations, and five texts.  He sits on the editorial board of the International Journal of Impotence Research and is the current editor of the Journal of Sex and Marital Therapy.  Dr. Segraves obtained his M.D. from Vanderbilt University, his PhD from the University of London, and completed his residency in psychiatry at the University of Chicago.

Dr. Pyke served as Director of Clinical Research at Boehringer Ingelheim Pharmaceuticals where he led the Flibanserin Worldwide premenopausal HSDD clinical program that ended in October 2010.  Dr. Pyke has a distinguished career of leading drug after drug to FDA approval with Parke-Davis, Bristol-Myers Squibb, and Upjohn.  He has continued his clinical practice treating anxiety, depression, and substance abuse.  Dr. Pyke is a member of numerous societies, including the International Society for the Study of Women's Sexual Health.  He completed his Ph.D. at the University of Wisconsin, Madison, obtained his M.D. at the University of Miami, and completed his medical training in Internal Medicine at the University of Michigan.

"I look forward to serving on the advisory board for this promising potential therapy," stated Pyke. "The field of sexual health is ever evolving and it's exciting to join a company that is on the leading edge of this evolution."

About S1 Pharmaceuticals, Inc.
S1 is an early-stage biopharmaceutical company developing therapeutic solutions for disorders of Women's Sexual Health.  The most common type of Female Sexual Dysfunction (FSD) is a loss of libido and lack of sexual interest known as Hypoactive Sexual Desire Disorder (HSDD).  S1 is developing its lead product, Lorexys, as an oral drug and will seek to demonstrate that Lorexys can be the first safe and effective treatment approved by the FDA for HSDD in women.

(201) 839-0941

SOURCE S1 Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
2. Cumberland Pharmaceuticals Ranks as one of the Fastest Growing Companies in North America on Deloittes 2011 Technology Fast 500™
3. Onyx Pharmaceuticals Announces Third Quarter 2011 Financial Results Teleconference and Webcast
4. Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1
5. Arrien Pharmaceuticals Appoints Dr. Philip LoGrasso to its Scientific Advisory Board for CNS/Neurodegenerative Diseases
6. Critical Alerts For Intel, Mosaic, Deckers, Foot Locker, and Jazz Pharmaceuticals Released By Seven Summits Research
7. Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl
8. Amylin Pharmaceuticals Reports Third Quarter Financial Results
9. CureFAKtor Pharmaceuticals to Present at 10th Annual BIO Investor Forum
10. ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26
11. Rock Creek Pharmaceuticals Announces Expanded International Shipping Options for Anatabloc™, Physician Conferences on Anatabine Research
Post Your Comments:
(Date:11/29/2015)... Iowa , Nov. 29, 2015 ... ultrasound guidance technology at the Radiological Society of ... in Chicago November 29 ... system is designed to offer customers unrivaled versatility, ... --> ...
(Date:11/27/2015)... YORK , November 27, 2015 ... system is set to go online. The potential to ... processes is vast and far from fully exploited as ... to patient health records, either via mobile tablet or ... ) --> ) --> ...
(Date:11/27/2015)... Research and Markets ( ) has ... Market 2015-2019" report to their offering. ... report, the author the present scenario and growth prospects ... calculate the market size, the report considers revenue generated ... IUDs and copper IUDs. The report forecasts the global ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 30, 2015 , ... ... new company, Sublime Beauty NATURALS®. All products are available on Amazon or its ... oils, organic facial serums and USDA Certified Organic Sesame Oil for Oil Pulling," ...
(Date:11/29/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... November 29, 2015 , ... ... football games, basketball games. Things that as a Mother and Wife would love to ... was no mistake that I just happened to call Dr. Zaidan first. They have ...
(Date:11/29/2015)... ... November 29, 2015 , ... NewsWatch featured X-wing as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... reality in the future. , It’s the future because flying cars are about to ...
(Date:11/29/2015)... ... ... While conventional walkers afford considerable help with mobility, their design does not ... inventor from Uniontown, Pa., has found a way to address those needs. , He ... walker to improve the user’s quality of life. To begin with, this improved mobility ...
(Date:11/29/2015)... Viejo, CA (PRWEB) , ... November 29, 2015 ... ... an all new and unique analog distortion effect tool designed specially for Final ... their footage, and create limiltess looks with the easy-to-use modification controls. Destoying and ...
Breaking Medicine News(10 mins):